Intellia Therapeutics


Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Industries

Employees

201-500

Links


Org chart

John Leonard
President & CEO
Collapse
Eliana Clark
EVP, CTO
David Lebwohl
EVP, Chief Medical Officer
Laura Sepp-Lorenzino
EVP, Chief Scientific Officer
Edward Dulac
EVP & CFO
Marika St. Amand
SVP, Chief Human Resources Officer
James Basta
EVP, General Counsel & Corporate Secretary
Aron Stein
SVP, Regulatory Affairs
Maria Natale
SVP, Commercial
James Butler
General Manager
Kathleen Shea
Sr. Executive Assistant To The CEO At Intellia Therapeutics
Caroline McAuley
Procurement Lead
Kern Francis
Manager Material Operations And Logistics
Adia Leung
Director, Clinical Operations
Jaclyn Martin
Vp, Market Access And Patient Services

Board & advisors

Andy May
Founder & Advisor
Rodolphe Barrangou
Founder & Advisor
Derrick Rossi
Founder & Advisor
Erik Sontheimer
Founder & Advisor
Nessan Bermingham
Founder & Advisor
Jennifer Doudna
Founder & Advisor
Luciano Marraffini
Founder & Advisor
Frank Verwiel
Board Member
Fred Cohen
Board Member
Jesse Goodman
Board Member
Georgia Keresty
Board Member
Muna Bhanji
Board Member
Bill Chase
Board Member
Brian Goff
Board Member